Sequencing the exomes of more than 50,000 patients, and integrating that information with their electronic health records (EHRs), has enabled researchers to identify gene variants that were associated with specific phenotypes, an approach that could enable the discovery of new drug targets. Read More
HONG KONG – Leveraging the country's expertise in high-tech manufacturing, more South Korean pharmaceutical companies are joining forces with local and global medical device companies. Consider Dong-A ST Co. Ltd., Dongkook Co. Ltd. and Dae Woong Pharmaceutical Co. Ltd., which have all recently struck up deals with med-tech companies to sell devices in South Korea. Read More
Quintiles IMS Holdings Inc. has formed a new collaborative initiative with four top biopharma companies to ferret out real-world data on the use of cancer treatments across seven top European markets. The Collaboration for Oncology Data in Europe, or CODE, is funded both by QuintilesIMS and four initial partners with an interest in the data: Bristol-Myers Squibb Co., Eli Lilly and Co., Merck KGaA and Pfizer Inc. Read More
Ascendance Biotechnology Inc., of Medford, Mass., said it executed a deal with GE Healthcare, providing Ascendance a right to manufacture, market and sell the GE Healthcare Cytiva brand of human stem cell-derived cardiomyocytes used for evaluating potential cardiotoxicity. Read More
Oncbiomune Pharmaceuticals Inc., of Baton Rouge, La., said it was advised that about 30 patients have been pre-screened for the phase II/III trial testing prostate cancer vaccine Proscavax in Mexico. Read More
